© 2021 MJH Life Sciences and Drug Topics. All rights reserved.
© 2021 MJH Life Sciences™ and Drug Topics. All rights reserved.
April 09, 2021
Store owners offer tips for supplying and giving shots.
April 08, 2021
A session at the American Pharmacists Association 2021 Annual Meeting and Exposition addressed recent immunization practice changes.
April 07, 2021
In part 2 of our interview, Rich Tremonte of AmerisourceBergen discusses distribution highlights, inspiring efforts from pharmacists, and the future of COVID-19 vaccination.
The FDA has made revisions to the emergency use authorization for the Moderna COVID-19 vaccine.
April 01, 2021
The vaccine is 91.3% effective against COVID-19 for up to 6 months after the second dose, according to an analysis of data collected through March 13.
March 31, 2021
Pfizer/BioNTech released data on their COVID-19 vaccine that indicates high efficacy in children aged 12 to 15 years.
March 29, 2021
A retrospectively analysis assessed the effect of a remote vaccination review process on vaccination status during the COVID-19 pandemic.
March 26, 2021
A team of researchers have released study results that show the Moderna and Pfizer vaccines are indeed safe and effective for this population.
March 25, 2021
The updated analyses of the AZD1222 COVID-19 vaccine will be submitted to the FDA for emergency use authorization, according to AstraZeneca.
March 24, 2021
A recent study looked at the role of the influenza vaccine in COVID-19 susceptibility and severity
March 23, 2021
AstraZeneca responded to the concerns by promising to release the most up-to-date data within 48 hours.
Increasing reports have surfaced of vaccine recipients experiencing delayed cutaneous side effects after receiving the first dose.
March 22, 2021
AstraZeneca is preparing to submit its COVID-19 vaccine data to the FDA for emergency use authorization in the coming weeks.
The CDC reported data demonstrating high adherence to COVID-19 vaccine doses among recipients.
March 16, 2021
Germany, Spain, Ireland, and France, among other EU countries, have decided to temporarily suspend the AstraZeneca COVID-19 vaccine amid reports of serious cases of blood clots.
March 15, 2021
NCPA lauded the higher reimbursement rate in a statement.
March 11, 2021
New survey results released by NCPA suggest that many Americans prefer to receive the COVID-19 vaccine from a local health care provider over a mass vaccination event.
Are we doing enough to protect those on the front lines?
March 08, 2021
The CDC has issued interim guidance for masking, social distancing, hand hygiene, and other infection control measures for people who are fully vaccinated for COVID-19.
In an opinion piece, pharmacist Pete Kreckel highlights the ways that women have been leading the COVID-19 vaccination effort.